CTSG and metastatic neoplasm: Consistently, the expression levels of two downregulated genes in OSCC, CTSG and LCORL, were decreased along with the progressed TNM staging, especially in patients with metastatic diseases (Figures 2(b) and 2(c), analysis of variance (ANOVA), P value < 0.05).